Amedisys (NASDAQ:AMED – Get Free Report) posted its quarterly earnings results on Wednesday. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19), Briefing.com reports. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. The firm had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. During the same quarter in the previous year, the company earned $0.98 earnings per share. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year.
Amedisys Price Performance
Shares of AMED stock traded down $0.91 during mid-day trading on Thursday, reaching $96.80. The stock had a trading volume of 371,727 shares, compared to its average volume of 337,228. Amedisys has a 12-month low of $89.55 and a 12-month high of $98.95. The company has a market cap of $3.17 billion, a P/E ratio of 34.90, a price-to-earnings-growth ratio of 1.87 and a beta of 0.78. The business has a 50-day simple moving average of $96.75 and a 200 day simple moving average of $95.77. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on AMED. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price objective on the stock. in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $100.67.
Amedisys Company Profile
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
See Also
- Five stocks we like better than Amedisys
- What is a SEC Filing?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Find Undervalued Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- The Significance of Brokerage Rankings in Stock Selection
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.